Phibro Animal Health (PAHC) Long-Term Deferred Tax (2019 - 2026)

Phibro Animal Health's Long-Term Deferred Tax history runs 8 years deep, the most recent figure standing at $15.3 million for Q1 2026.

• On a quarterly basis, Long-Term Deferred Tax fell 57.8% year-over-year to $15.3 million in Q1 2026; TTM through Mar 2026 was $15.3 million, a 57.8% decrease from a year earlier, with the FY2025 full-year figure at $25.5 million, up 31.89% from the prior year.
• Long-Term Deferred Tax retreated to $15.3 million in Q1 2026 per PAHC's latest filing, from $19.5 million in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $36.2 million in Q1 2025 and bottomed at $4.1 million in Q1 2022.
• The 5-year median for Long-Term Deferred Tax is $14.5 million (2024), against an average of $16.1 million.
• Across the five-year window, Long-Term Deferred Tax surged 184.22% in 2024 and sank 57.8% in 2026, its largest moves.
• Year by year, Long-Term Deferred Tax stood at $6.3 million in 2022, then soared by 123.91% to $14.1 million in 2023, then jumped by 139.16% to $33.8 million in 2024, then sank by 42.29% to $19.5 million in 2025, then retreated by 21.74% to $15.3 million in 2026.
• Per Business Quant, the three latest PAHC Long-Term Deferred Tax figures stand at $15.3 million (Q1 2026), $19.5 million (Q4 2025), and $23.5 million (Q3 2025).